v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Mar. 30, 2013
Mar. 24, 2012
OPERATING ACTIVITIES    
Net loss $ (47,986) $ (19,461)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation 46,218 32,181
Amortization 208,213 121,983
Non-cash interest expense 41,387 38,881
Stock-based compensation expense 31,079 17,606
Excess tax benefit related to equity awards (4,437) (2,683)
Deferred income taxes (92,502) (103,088)
Gain on sale of intellectual property (53,884) (12,424)
Debt extinguishment loss 3,247 42,347
Fair value adjustments to contingent consideration 10,839 48,310
Fair value write-up of inventory sold 52,397  
Cost method equity investment impairment 1,733  
Non-cash restructuring charges 47 15,316
Loss on disposal of property and equipment 2,198 1,313
Other 1,976 (3,143)
Changes in operating assets and liabilities:    
Accounts receivable 8,627 (7,573)
Inventories (3,719) (11,889)
Prepaid income taxes (16,700) 324
Prepaid expenses and other assets 1,225 (3,574)
Accounts payable (12,939) 2,339
Accrued expenses and other liabilities (11,799) 50,439
Deferred revenue 4,308 5,631
Net cash provided by operating activities 169,528 212,835
INVESTING ACTIVITIES    
Acquisition of a business (3,918)  
Payment of additional acquisition consideration (16,808) (9,784)
Proceeds from sale of business, net of cash transferred 86,250  
Purchase of property and equipment (25,888) (14,232)
Increase in equipment under customer usage agreements (20,955) (19,325)
Purchase of insurance contracts (4,000)  
Proceeds from sale of intellectual property 60,000 12,500
Purchase of cost method investments (3,625) (250)
(Increase) decrease in other assets (4,951) 1
Net cash provided by (used in) investing activities 66,105 (31,090)
FINANCING ACTIVITIES    
Repayment of long-term debt (32,500)  
Payment of debt issuance cost (7,019) (5,822)
Payment of contingent consideration (42,433) (51,680)
Net proceeds from issuance of common stock pursuant to employee stock plans 37,623 20,389
Excess tax benefit related to equity awards 4,437 2,683
Payment of employee restricted stock minimum tax withholdings (9,972) (5,696)
Net cash used in financing activities (49,864) (40,126)
Effect of exchange rate changes on cash and cash equivalents (1,203) 610
Net increase in cash and cash equivalents 184,566 142,229
Cash and cash equivalents, beginning of period 560,430 712,332
Cash and cash equivalents, end of period $ 744,996 $ 854,561